We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wrong Numbers, Unsecure Emails Among Pitfalls in ANDAs
Wrong Numbers, Unsecure Emails Among Pitfalls in ANDAs
Wrong telephone numbers, unsecure email addresses and inconsistent sponsor names are among the common mistakes the FDA sees in regulatory submissions for generics that can trigger delays in the review process.